A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
2016 · Nature Communications · 248 citations
https://doi.org/10.1038/ncomms11505
C
Chaoyang Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
2.8K
Citations
29
h-index
69
i10-index
Chaoyang Li is an academic researcher from Guangzhou Medical University Cancer Hospital. The author has contributed to research in topics: Prion Diseases and Protein Misfolding & RNA regulation and disease & Trace Elements in Health. The author has an h-index of 29, co-authored 116 publications.
ORCID: 0000-0003-3582-4141Papers by this author
worksBinding of Recombinant but Not Endogenous Prion Protein to DNA Causes DNA Internalization and Expression in Mammalian Cells
2008 · Journal of Biological Chemistry · 26 citations
https://doi.org/10.1074/jbc.m800814200
Prion Protein Protects Cancer Cells against Endoplasmic Reticulum Stress Induced Apoptosis
2019 · Virologica Sinica · 25 citations
https://doi.org/10.1007/s12250-019-00107-2
Accuracy benchmark of the GeneMind GenoLab M sequencing platform for WGS and WES analysis
2022 · BMC Genomics · 24 citations
https://doi.org/10.1186/s12864-022-08775-3
Cuproptosis and Serine Metabolism Blockade Triggered by Copper‐Based Prussian Blue Nanomedicine for Enhanced Tumor Therapy
2024 · Small · 8 citations
https://doi.org/10.1002/smll.202406942
Protocol to differentiate glycosylphosphatidylinositol-anchored prion protein from pro-prion protein in cancer cells
2023 · STAR Protocols · 1 citations
https://doi.org/10.1016/j.xpro.2023.102298
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat